Dr. Victor Martin Moles, MD

Dr. Moles practices at University Hospital in Ann Arbor, Michigan.

Dr. Moles' NPI, 1861703092, was assigned on June 22, 2010. Dr. Moles holds Michigan license 4301104800.

Dr. Moles' primary practice is University Hospital, at 1500 E Medical Center Dr, Ann Arbor, MI 48109. The practice phone is (734) 936-4000.

Dr. Moles' primary practice is University Hospital in Ann Arbor, Michigan. Dr. Moles is also affiliated with University Hospital. The medical group on file is University of Michigan Health. Dmand AI also links Dr. Moles to 1 more hospital, named with a free account. Dr. Moles' employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moles practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Moles' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Moles is licensed in Michigan.

CMS data shows 1,337 Medicare services from Dr. Moles across 15 procedure codes in 2024, for 601 Medicare patients. Medicare paid $55,356 for them.

CMS counts 601 Medicare patients who saw Dr. Moles in 2024. The largest group is 65 to 74, with 245 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moles' median patient age at 66, with 51% women.

In 2024, Dr. Moles wrote 1,949 Medicare Part D claims for 210 patients. 51% of them were for generic drugs. CMS names the drug for 1,787 of them, across 29 drugs with 11 or more claims each, at $13,315,428 in total drug cost. In 2023, CMS named 1,546 claims across 30 drugs.

Dr. Moles accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moles as offering telehealth.

Dmand AI links 19 papers to Dr. Moles, published from 2016 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Hypertension, Pulmonary, Pulmonary Arterial Hypertension and Pulmonary Embolism. Dr. Moles has published most often in J Soc Cardiovasc Angiogr Interv. Dr. Moles' most frequent co-authors are Vallerie Victoria McLaughlin, MD, Vikas Aggarwal, MD and Jonathan William Haft, MD.

Dmand AI links Dr. Moles to 3 clinical trials, 3 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Pulmonary Arterial Hypertension and Hypertension, Pulmonary. Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA sponsors the most, 3.

CMS Open Payments shows 113 general payments to Dr. Moles from 5 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 48% of the total. Merck Sharp & Dohme Corporation paid the most, $104,707.